Insider Title Company Date Price Return Shares Value
Lim Bryant David CLO, Interim CFO, Corp Sec. Prelude Therapeutics Inc (PRLD) 2024-12-19 $0.91 0.0% 25,000 $22,638
Lim Bryant David Chief Legal Officer, Corp Sec. Prelude Therapeutics Inc (PRLD) 2023-05-24 $5.39 -10.8% 2,400 $12,936
Return Profit / (loss) Cost
Total -3.9% $-1,392 $35,574